Luke J. Bergstrom
Partner
San Francisco / Silicon Valley
luke.bergstrom@lw.com
+1.650.463.3083
PRACTICES
- Emerging Companies & Growth
- Mergers & Acquisitions
- Private Equity
INDUSTRIES
- Artificial Intelligence
- Healthcare & Life Sciences
- Technology
EDUCATION
- JD, University of Pittsburgh School of Law,
- MA, University of Chicago,
- BA, University of Maryland,
LANGUAGES SPOKEN
PROFILE
Luke Bergstrom, former Global Vice Chair of the firm's Technology Industry Group and former Global Co-Chair of the Mergers & Acquisitions Practice, regularly advises leading corporate and private equity clients on significant M&A transactions and related sensitive matters.
Luke advises companies and private equity firms, drawing on more than two decades of experience handling a full spectrum of transactions. He combines strong negotiation skills, a deep commercial sensibility, and a proven ability to lead teams that leverage the firm’s global resources to help clients achieve their objectives in the most effective and cost-efficient manner.
Consistently ranked among the top M&A lawyers in the country, clients describe him as a “sophisticated, pragmatic” lawyer who “looks for solutions and wants to facilitate a deal.”
EXPERIENCE
Luke's recent experience includes transactions in the following industries:
Software and Information Technology
- Intuit Inc., a provider of business and financial management solutions for small businesses, consumers, and accounting professionals, in numerous transactions, including its:
- US$12 billion acquisition of Mailchimp
- US$7.1 billion acquisition of Credit Karma
- US$340 million acquisition of TSheets, Inc.
- US$1.025 billion sale of Digital Insight, Intuit’s Financial Services division, to Thoma Bravo
- US$423 million acquisition of Demandforce, Inc. and its subsequent sale to Internet Brands
- US$360 million acquisition of Check
- Neudesic, a leading cloud services consultancy, in its sale to IBM
- Astound Commerce, a global digital commerce specialist, in its sale of a majority interest to RLH Equity Partners
- PriceSpider, a leading brand commerce company revolutionizing retail data technology, in its sale of a majority interest to Frontier Capital
- Pipedrive, a sales CRM Platform, in its sale of a majority interest to Vista Equity Partners
- Bread Financial (formerly Alliance Data Systems), in various transactions, including the sale of its Epsilon business unit to Publicis Group
Internet & Digital Media
- Indeed.com, the American worldwide employment website for job listings, in various acquisitions
- Khosla Ventures Acquisition Co. II in its deSPAC merger with NextDoor, the online neighborhood network
- Chess.com, one of the world's largest online chess platforms, in its sale of a substantial growth investment to General Atlantic
- OpenTable, Inc., a web-based service provider of restaurant reservations, in its US$2.6 billion sale to the Priceline Group
- Twitch Interactive, Inc., an operator of a live video platform for online gaming, in its US$970 million sale to a multi-national technology company
- eBay Inc. in its US$945 million acquisition of Bill Me Later, Inc.
- Seamless North America, LLC, a leading provider of mobile and online portals that provide restaurant information and services, in its merger with GrubHub
Semiconductors
- Avago Technologies Limited, a provider of analog semiconductors, custom chips, radio-frequency and microwave components, in its:
- US$37 billion acquisition of Broadcom Corp.
- US$6.6 billion acquisition of LSI Corporation
- US$400 million acquisition of CyOptics
- US$240 million sale of its Printer ASICs business to Marvell Technology Group Ltd.
- US$70 million sale of its CMOS image sensor business to Micron Technology
- IXYS Corporation, a provider of power semiconductors, radio frequency power semiconductors, and digital and analog integrated circuits, in various transactions, including its sale to Littelfuse
Life Sciences
- Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company, in its acquisition by Merck
- MAP Pharmaceuticals, Inc., a drug and pharmaceutical company, in its US$958 million sale to Allergan, Inc.
- Labrys Biologics, Inc., a biotechnology firm developing antibody treatments for chronic migraines, in its US$825 million sale to Teva Pharmaceutical Industries
- FerroKin BioSciences, Inc., a biotechnology company, in its US$325 million sale to Shire plc
- KAI Pharmaceuticals, a privately held pharmaceuticals company, in its US$315 million sale to Amgen
- Complete Genomics, Inc., a developer of DNA sequencing products and services, in its US$117 million sale to BGI Shenzhen
- Pionyr Immunotherapeutics, a clinical stage company developing cancer therapies, in its negotiation with Gilead Sciences of a structured financing and option to purchase Pionyr
- Transcept Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of proprietary products in the neuroscience field, in its reverse merger with Paratek Pharmaceuticals
Medical Devices
- Sorin S.p.A., a global medical device company, in its US$2.7 billion merger with Cyberonics
- Ulthera, a medical device company focused on the development and commercialization of various technologies for aesthetic and medical applications, in its:
- US$600 million sale to Merz
- Acquisition of Cabochon Aesthetics
- Sadra Medical, Inc., a company pioneering new therapies to minimize the invasiveness of treating aortic valve disease, in its US$450 million sale to Boston Scientific Corporation
- Maya Medical, a nascent hypertension product company, in its US$230 million sale to Covidien
- Zonare Medical Systems, a US based ultrasound company, in its US$105 million sale to Mindray Medical International Limited
- FlowCardia, Inc., a California medical device company, in its sale to C. R. Bard, Inc.
- Hotspur Technologies, Inc., a developer of catheter-based technologies, in its sale to Teleflex Medical, Inc.
- Harpoon Medical, a medical device company focused on the treatment of heart disease, in its negotiation with Edwards Lifesciences of a structured financing and option to purchase Harpoon
- Kalila Medical, a medical device company developing steerable catheter technologies for atrial fibrillation and other electrophysiology procedures, in its sale to Abbott Laboratories
Private Equity
Luke's private equity experience includes:
- ArchiMed SAS and its various portfolio companies in numerous transactions, including ArchiMed’s pending acquisition of Natus Medical
- The Veritas Capital Vantage Fund and its various portfolio companies in numerous acquisitions
- Behrman Capital in various transactions, including most recently, its sales of Pelican Products, New ILC Dover and Data Device Corporation
- SRS Acquiom in its sale of a majority interest to Lovell Minnick Partners
- Canada Pension Plan Investment Board, in its acquisition of a 48% stake in GlobalLogic, Inc. a global leader in digital product development services
- Bridgepoint Advisers, in its acquisition with Summit Partners of Calypso Technology, a provider of financial market software solutions